Key Highlights
- UNFI shares rose 7.79% in today's session to $52.16 from a prior close of $48.39.
- Goldman Sachs upgraded the stock to Buy from Neutral.
- The firm raised its price target to $60 from $49.
- Fiscal 2027 adjusted EPS guidance is $3.00 to $3.50.
United Natural Foods (NYSE:UNFI) shares rose in today's session after Goldman Sachs upgraded the grocery wholesaler to Buy from Neutral. The stock was at $52.16, up 7.79% from the prior close of $48.39, on Volume of about 454,000 shares. The shares are up roughly 44% to 48% year to date, and the 52-week range runs from $30.91 to $57.02.
United Natural Foods, based in Providence, Rhode Island, is the largest publicly traded wholesale food distributor in North America. It supplies natural, organic, specialty, fresh and conventional grocery products to about 30,000 retail locations in the US and Canada, and Whole Foods Market is a key account.
What Did Goldman Sachs Say?
Goldman Sachs raised its price target to $60 from $49. The firm cited room for EBITDA growth from the company's exposure to natural and organic foods, better execution after network changes and a cost-plus contract structure that could benefit from re-accelerating food-at-home inflation.
What Did the Latest Quarterly Report Show?
In its fiscal fourth-quarter report in September, UNFI posted adjusted EPS of $0.69 against a $0.62 estimate, while Revenue of $7.6 billion was slightly below the $7.7 billion estimate. Adjusted EBITDA was $172 million for the quarter and $701 million for the year, up 27%. Free Cash Flow was $80 million in the quarter and $323 million for the year, and net Leverage fell to 2.2 times.
Fiscal 2026 net sales were about $31.2 billion. Adjusted gross Margin was 13.7% in the quarter, up about 30 basis points. The company announced a new $200 million share repurchase program and repurchased about 1.25 million shares for roughly $50 million in fiscal 2026. It also named Matteo Tarditi to an expanded role as President and COO and is onboarding CFO Alfredo Luchini.
What Does Fiscal 2027 Guidance Call For?
Guidance includes sales of $31.2 billion to $31.8 billion, adjusted EBITDA of $730 million to $780 million, adjusted EPS of $3.00 to $3.50 and free cash flow of $275 million to $325 million. Capital expenditures are expected at about $300 million, and net leverage is expected to fall below 2.0 times by year-end. Adjusted EBITDA for fiscal 2028 is expected to grow about 10% over the fiscal 2027 guidance midpoint.
First-Quarter Results on December 8 Set the Next Checkpoint
Consensus is still mostly Hold, and investors are looking ahead to first-quarter fiscal 2027 results on December 8. The company expects first-quarter sales to decline year over year before growth returns in the second half.



_11_17_2026_19_00_23_927509.jpg)


Please wait processing your request...